Patent · US Active

Adeno-associated viral vectors for gene therapy

US11098325B2 · kind B2 · utility

0Cited by

57References

20Claims

0Family size

Assignee

INTIMA BIOSCIENCE, INC. · US

Inventors

Thomas HENLEY · Havertown, US
Mavis Agbandje-McKenna · Gainesville, US
Tilmann Buerckstuemmer · Wien, AT
Lydia VINEY · London, GB
Modassir Choudhry · New York, US

Key dates

Filing date	Dec 18, 2019
Grant date	Aug 24, 2021
Priority date	—
Expiry date	Dec 18, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2750/14145
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Genetically modified compositions, such as adeno-associated viral vectors and primary cells, for treating various conditions and diseases. Disclosed are also modified adeno-associated viruses for the treatment of cancer. Also disclosed are the methods of making and using the genetically modified compositions in treating various diseases, conditions, and cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.